DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹2.00 Cr | - | - | - | ₹0.35 Cr |
What is the latest Total Debt ratio of DIVIS LABORATORIES ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹2.00 Cr |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | ₹0.35 Cr |
How is Total Debt of DIVIS LABORATORIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.00 Cr | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | -100.00 | |
| Mar2021 | ₹0.35 Cr | - | |
Compare Total Debt of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹169,778.0 Cr | -1.6% | -0.4% | 9.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,626.0 Cr | -1% | -4.9% | -7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,021.0 Cr | 0.2% | 2.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹122,046.0 Cr | 1% | -0.9% | -1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,086.0 Cr | 0.4% | 0.9% | -8.9% | Stock Analytics | |
| MANKIND PHARMA | ₹90,666.4 Cr | 0.1% | -1.5% | -25.1% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -1.6% |
-0.4% |
9.4% |
| SENSEX | -0.4% |
-0.6% |
8.6% |
You may also like the below Video Courses